Cargando…
Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study
Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738109/ https://www.ncbi.nlm.nih.gov/pubmed/33327274 http://dx.doi.org/10.1097/MD.0000000000023440 |
_version_ | 1783623062950772736 |
---|---|
author | Huang, Hung-Yu Lu, Min-Wei Chen, Mei-Chi Chang, Hsiu-Mei Kuo, Chih-Hsi Lin, Shu-Min Wang, Chun-Hua Chung, Fu-Tsai |
author_facet | Huang, Hung-Yu Lu, Min-Wei Chen, Mei-Chi Chang, Hsiu-Mei Kuo, Chih-Hsi Lin, Shu-Min Wang, Chun-Hua Chung, Fu-Tsai |
author_sort | Huang, Hung-Yu |
collection | PubMed |
description | Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer generally excluded patients with a previous diagnosis of malignancy. The study aimed to investigate the outcome of second primary lung cancer and the factor that improve survival in patients with hepato-GI cancer. A total of 276 patients with secondary lung cancer were found among 3723 newly-diagnosed lung cancer patients diagnosed in Chang Gung Memorial Hospital, between 2010 and 2014. Patients’ clinical characteristics, stages and survival were recorded and analyzed. The patients were separated into 2 groups: Group I was defined as lung cancer detected in original primary cancer clinic and group II patients defined as lung cancer detected in other medical places. Sixty-nine cases with primary GI-hepatic and secondary lung cancer were diagnosed (42 (60.8%) in Group I and 27 (39.1%) in Group II). Although both groups had comparable primary cancer stages and treatment, more patients in Group I than Group II were diagnosed as early stage lung cancer (stage I-II: 40.5% vs 11.1%; P = .023). Group II had larger lung tumor sizes than Group I (4.7 vs 3.5 cm; P = .025). Group I showed better 5-year overall survival than Group II (P = .014, median survival: 27 vs 10 months). Among Group II, only 37% had received image follow up in clinic compared with 67% of Group I cases (P = .025). Patients with chest image follow up in clinics also had better 5-year overall survival (P = .043). GI-hepatic cancer was the most common primary malignancy in the lung cancer cohort. Patients had better survival outcome when secondary lung cancer was diagnosed in original primary cancer clinic. Chest image screening strategy may contribute better survival in secondary lung cancer due to detection at an earlier stage. |
format | Online Article Text |
id | pubmed-7738109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-77381092020-12-16 Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study Huang, Hung-Yu Lu, Min-Wei Chen, Mei-Chi Chang, Hsiu-Mei Kuo, Chih-Hsi Lin, Shu-Min Wang, Chun-Hua Chung, Fu-Tsai Medicine (Baltimore) 6700 Second primary cancer is prevalent in patients with gastrointestinal (GI) cancer, for which lung cancer is the most common and associated with high lethality. Image screening for lung cancer was proved to be effective in early diagnosis and lower mortality. However, trials of screen for lung cancer generally excluded patients with a previous diagnosis of malignancy. The study aimed to investigate the outcome of second primary lung cancer and the factor that improve survival in patients with hepato-GI cancer. A total of 276 patients with secondary lung cancer were found among 3723 newly-diagnosed lung cancer patients diagnosed in Chang Gung Memorial Hospital, between 2010 and 2014. Patients’ clinical characteristics, stages and survival were recorded and analyzed. The patients were separated into 2 groups: Group I was defined as lung cancer detected in original primary cancer clinic and group II patients defined as lung cancer detected in other medical places. Sixty-nine cases with primary GI-hepatic and secondary lung cancer were diagnosed (42 (60.8%) in Group I and 27 (39.1%) in Group II). Although both groups had comparable primary cancer stages and treatment, more patients in Group I than Group II were diagnosed as early stage lung cancer (stage I-II: 40.5% vs 11.1%; P = .023). Group II had larger lung tumor sizes than Group I (4.7 vs 3.5 cm; P = .025). Group I showed better 5-year overall survival than Group II (P = .014, median survival: 27 vs 10 months). Among Group II, only 37% had received image follow up in clinic compared with 67% of Group I cases (P = .025). Patients with chest image follow up in clinics also had better 5-year overall survival (P = .043). GI-hepatic cancer was the most common primary malignancy in the lung cancer cohort. Patients had better survival outcome when secondary lung cancer was diagnosed in original primary cancer clinic. Chest image screening strategy may contribute better survival in secondary lung cancer due to detection at an earlier stage. Lippincott Williams & Wilkins 2020-12-11 /pmc/articles/PMC7738109/ /pubmed/33327274 http://dx.doi.org/10.1097/MD.0000000000023440 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 6700 Huang, Hung-Yu Lu, Min-Wei Chen, Mei-Chi Chang, Hsiu-Mei Kuo, Chih-Hsi Lin, Shu-Min Wang, Chun-Hua Chung, Fu-Tsai Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title | Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title_full | Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title_fullStr | Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title_full_unstemmed | Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title_short | Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study |
title_sort | clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: a strobe-compliant retrospective study |
topic | 6700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738109/ https://www.ncbi.nlm.nih.gov/pubmed/33327274 http://dx.doi.org/10.1097/MD.0000000000023440 |
work_keys_str_mv | AT huanghungyu clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT luminwei clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT chenmeichi clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT changhsiumei clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT kuochihhsi clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT linshumin clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT wangchunhua clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy AT chungfutsai clinicimagesurveillancereducesmortalityinpatientswithprimaryhepatogastrointestinalcancerwhodevelopsecondprimarylungcancerastrobecompliantretrospectivestudy |